BOYA
Lv1
50 积分
2022-04-03 加入
-
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
10天前
已完结
-
Fcγ receptors: genetic variation, function, and disease
1个月前
已完结
-
Targeted ITP strategies: Do they elucidate the biology of ITP and related disorders?
4个月前
已完结
-
Thrombopoietin
4个月前
已完结
-
Histopathologic Characterization of Mogamulizumab-associated Rash
4个月前
已完结
-
Histopathologic Characterization of Mogamulizumab-associated Rash
4个月前
已完结
-
Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T‐Cell Lymphoma or Adult T‐Cell Lymphoma
4个月前
已完结
-
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis
4个月前
已完结
-
Breast cancer
4个月前
已完结
-
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
5个月前
已完结